FMOGS-OX2 Antibody

What is FMOGS-OX2 and what biological function does it serve?

FMOGS-OX2 is a gene encoding an enzyme involved in glucosinolate (GSL) biosynthesis in plants, particularly in Brassicaceae species. This enzyme participates in side chain modification of glucosinolates, which are important secondary metabolites in plants. The FMOGS-OX2 gene expressed differentially in radish taproots and siliques produces different aliphatic GSLs components—specifically, glucoraphasatin (GRH) in radish taproots and glucoerucin (GRE) in seeds . This tissue-specific expression pattern suggests that FMOGS-OX2 plays a crucial role in determining the specific glucosinolate profile in different plant organs, contributing to both plant defense mechanisms and the distinctive flavor profiles of edible Brassicaceae crops.

What applications are available for FMOGS-OX2 antibodies in plant research?

FMOGS-OX2 antibodies are primarily used in Western Blot (WB) and ELISA applications for plant research . These antibodies enable researchers to:

• Detect and quantify FMOGS-OX2 protein expression levels in different plant tissues

• Compare protein expression between different plant genotypes (high vs. low glucosinolate producers)

• Monitor changes in FMOGS-OX2 expression under various environmental conditions or stresses

• Validate transcriptomic data with protein-level confirmation

• Investigate post-translational modifications and protein-protein interactions within the glucosinolate biosynthetic pathway

How does FMOGS-OX2 contribute to glucosinolate profiles in plants?

FMOGS-OX2 plays a specific role in determining glucosinolate composition in different plant tissues. Research indicates that FMOGS-OX2 is involved in the production of glucoraphasatin (GRH) in radish taproots and glucoerucin (GRE) in seeds . This tissue-specific expression pattern contributes to the unique glucosinolate profiles observed in different plant organs. Understanding this enzyme's activity helps explain why certain plant tissues contain specific glucosinolate compounds, which has implications for both plant defense strategies and the nutritional and flavor qualities of edible Brassicaceae crops such as radish, broccoli, and mustard.

What is the optimal protocol for protein extraction when using FMOGS-OX2 antibodies?

For effective protein extraction when working with FMOGS-OX2 antibodies, the following methodological approach is recommended:

• Tissue collection and preparation:

  • Harvest plant tissue and immediately flash-freeze in liquid nitrogen

  • Grind frozen tissue to a fine powder using a mortar and pestle (maintain frozen state)

  • Transfer approximately 200 mg of powder to a pre-chilled tube

• Protein extraction buffer components:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% Triton X-100 or NP-40

  • 0.5% sodium deoxycholate

  • 1 mM EDTA

  • Protease inhibitor cocktail (freshly added)

  • 5 mM DTT or 2-mercaptoethanol (to preserve protein integrity)

  • 2% polyvinylpolypyrrolidone (PVPP) to remove phenolic compounds

• Extraction procedure:

  • Add 500-800 μl extraction buffer to the tissue powder

  • Vortex thoroughly and incubate with gentle agitation at 4°C for 30 minutes

  • Centrifuge at 15,000 × g at 4°C for 15 minutes

  • Carefully collect the supernatant containing soluble proteins

  • Quantify protein concentration using Bradford or BCA assay

This protocol is designed to effectively solubilize FMOGS-OX2 while minimizing interference from plant-specific compounds that could affect antibody binding or downstream applications.

How should FMOGS-OX2 antibodies be optimized for Western blot detection?

To optimize Western blot detection using FMOGS-OX2 antibodies:

• Sample preparation:

  • Load 20-50 μg of total protein per lane

  • Include positive controls (tissue known to express FMOGS-OX2) and negative controls

  • Use fresh DTT in sample buffer to ensure complete protein denaturation

• Electrophoresis and transfer considerations:

  • Use 10-12% polyacrylamide gels for optimal resolution

  • Run at 80-100V to ensure clean separation

  • Transfer to PVDF membrane (recommended over nitrocellulose for plant proteins)

  • Use wet transfer method at 100V for 1 hour or 30V overnight at 4°C

• Antibody optimization:

  • Blocking: Test both 5% non-fat milk and 3% BSA in TBST to determine optimal blocking agent

  • Primary antibody: Perform titration experiments (1:500, 1:1000, 1:2000, 1:5000) to determine optimal dilution

  • Incubation time: Compare 1-hour room temperature vs. overnight 4°C incubations

  • Washing: Optimize number and duration of wash steps (typically 3-5 washes of 5-10 minutes each)

• Signal detection considerations:

  • Choose appropriate detection method based on expected expression level (standard ECL vs. enhanced sensitivity systems)

  • Optimize exposure times to prevent saturation while capturing weak signals

  • Use digital imaging systems for more accurate quantification

This systematic optimization approach will help ensure specific detection of FMOGS-OX2 with minimal background interference.

What controls are essential when performing ELISA with FMOGS-OX2 antibodies?

When conducting ELISA experiments with FMOGS-OX2 antibodies, the following controls are essential:

• Assay validation controls:

  • Standard curve: Generate using recombinant FMOGS-OX2 protein (if available) or extracts from tissues with known FMOGS-OX2 expression levels

  • Blank control: Buffer-only wells to establish baseline signal

  • Zero standard: Sample matrix without FMOGS-OX2 to assess matrix effects

• Sample-specific controls:

  • Positive control: Extract from plant tissue known to express high levels of FMOGS-OX2

  • Negative control: Extract from:

    • FMOGS-OX2 knockout/knockdown plants

    • Tissue types known not to express FMOGS-OX2

  • Dilution linearity: Serial dilutions of samples to verify signal proportionality

• Antibody specificity controls:

  • Antigen competition: Pre-incubation of antibody with purified antigen to confirm specificity

  • Secondary antibody control: Omit primary antibody to assess non-specific binding

  • Isotype control: Use non-specific antibody of same isotype to evaluate background

• Assay performance indicators:

  • Intra-assay replicates: Minimum of 3 technical replicates to assess precision

  • Inter-assay calibrators: Common samples run across plates/days to normalize between experiments

  • Spike-recovery: Known amounts of target protein added to samples to assess recovery efficiency

The washing protocol should be carefully optimized during experimental design to determine the correct number, duration, and volume of wash steps required . Implementing these controls ensures reliable, reproducible, and specific detection of FMOGS-OX2 in plant samples.

How can FMOGS-OX2 antibodies be integrated with metabolomic analyses to study glucosinolate pathway regulation?

Integrating FMOGS-OX2 antibody-based protein detection with metabolomic analyses requires a carefully designed experimental approach:

• Coordinated sample collection strategy:

  • Harvest identical plant tissue samples in parallel for both protein and metabolite analyses

  • Include sufficient biological replicates (n≥5) to account for natural variation

  • Consider time-course experiments to capture dynamic relationships between enzyme expression and metabolite accumulation

• FMOGS-OX2 protein quantification methods:

  • Western blot analysis with densitometry for semi-quantitative assessment

  • ELISA for more precise quantification across multiple samples

  • Normalize to appropriate housekeeping proteins or total protein content

• Glucosinolate metabolite analysis protocol:

  • Extract glucosinolates using the established method described in the literature:

    • Incubate 200 mg dried tissue with 5 mL 100% methanol at 83°C for 20 minutes

    • Add glucotropaeolin as internal standard

    • Perform secondary extractions with 70% methanol

    • Process through DEAE columns and desulfate with sulfatase overnight

    • Analyze by HPLC with UV detection at 230 nm

• Integrated data analysis approach:

  • Calculate Pearson correlation coefficients between FMOGS-OX2 protein levels and specific glucosinolate compounds

  • Perform principal component analysis to identify patterns in the combined dataset

  • Develop a co-expression network similar to the approach described for transcriptomic data :

    • Calculate correlation coefficients between protein levels and metabolite concentrations

    • Determine significance levels (p ≤ 0.01)

    • Visualize relationships using network analysis tools such as Cytoscape

This integrated approach provides powerful insights into how FMOGS-OX2 protein expression directly influences glucosinolate profiles, moving beyond transcriptomic correlations to establish protein-metabolite relationships.

What methodological considerations are important when studying FMOGS-OX2 expression in different plant genotypes?

When investigating FMOGS-OX2 expression across different plant genotypes (such as high vs. low glucosinolate producers), several methodological considerations are critical:

• Experimental design factors:

  • Growth conditions: Standardize all environmental parameters (light, temperature, nutrients, etc.) to minimize non-genetic variability

  • Developmental staging: Compare tissues at equivalent developmental stages rather than chronological age

  • Tissue sampling: Precisely define and consistently collect the same tissue regions across genotypes

  • Biological replication: Include sufficient individuals (n≥5 per genotype) to account for intra-genotype variation

• Multi-level expression analysis:

  • Transcriptional analysis:

    • RT-qPCR using gene-specific primers for FMOGS-OX2

    • RNA-seq for genome-wide context using methods described in the literature:

      • Process RNA-seq data to obtain normalized read counts (FPKM values)

      • Apply stringent criteria for identifying differentially expressed genes (absolute FC ≥ 2 and FDR ≤ 0.01)

  • Protein analysis:

    • Western blot for semi-quantitative comparison

    • ELISA for more precise quantification

    • Normalize to appropriate reference proteins or total protein

• Genotype verification and characterization:

  • Confirm genotype identity through molecular markers

  • Characterize glucosinolate profiles using established HPLC methods

  • Document any phenotypic differences that might influence metabolism

• Data integration strategy:

  • Compare expression patterns across transcriptomic and proteomic levels

  • Correlate expression with glucosinolate content

  • Develop visualization methods that clearly present differences between genotypes

This comprehensive approach allows for robust comparison of FMOGS-OX2 expression across genotypes while accounting for experimental variables that might influence results.

How can researchers investigate post-translational modifications of FMOGS-OX2?

Investigating post-translational modifications (PTMs) of FMOGS-OX2 requires specialized methodological approaches:

• PTM-specific detection strategies:

  • Phosphorylation analysis:

    • Use phospho-specific antibodies if available

    • Perform Western blots with and without phosphatase treatment

    • Look for mobility shifts in protein migration

  • Glycosylation assessment:

    • Treat protein extracts with deglycosylation enzymes (PNGase F, O-glycosidase)

    • Compare migration patterns before and after treatment

    • Use glycoprotein-specific stains (PAS staining)

  • Ubiquitination detection:

    • Immunoprecipitate FMOGS-OX2 and probe with anti-ubiquitin antibodies

    • Use proteasome inhibitors to enhance detection of ubiquitinated forms

• Mass spectrometry-based approaches:

  • Sample preparation:

    • Immunoprecipitate FMOGS-OX2 using validated antibodies

    • Perform in-gel or in-solution digestion with appropriate proteases

  • MS analysis:

    • Use LC-MS/MS with high mass accuracy

    • Implement neutral loss scanning for phosphorylation

    • Apply electron transfer dissociation for glycosylation analysis

  • Data analysis:

    • Search against appropriate plant protein databases

    • Include variable modifications in search parameters

    • Validate PTM identifications with appropriate statistical methods

• Functional significance assessment:

  • Generate site-directed mutants of putative modification sites

  • Express wild-type and mutant forms in appropriate plant systems

  • Compare enzymatic activity and protein stability

  • Assess impact on protein-protein interactions within the glucosinolate pathway

This systematic approach allows researchers to identify specific PTMs on FMOGS-OX2 and understand their functional significance in regulating enzyme activity and stability.

What are common problems encountered when using FMOGS-OX2 antibodies in plant samples?

When working with FMOGS-OX2 antibodies in plant samples, researchers frequently encounter several challenges:

• High background signal issues:

  • Problem: Non-specific binding resulting in high background on Western blots or in ELISA

  • Methodological solutions:

    • Increase blocking time or concentration (test 5% milk vs. 3-5% BSA)

    • Add 0.1-0.3% plant-specific blocking agents (e.g., plant protein extract from non-expressing tissue)

    • Increase detergent concentration in wash buffers (0.1-0.3% Tween-20)

    • Perform additional wash steps with longer duration

    • Pre-absorb antibody with non-expressing plant tissue extract

• Weak or inconsistent signal:

  • Problem: Low or variable detection of FMOGS-OX2 despite adequate expression

  • Methodological solutions:

    • Optimize protein extraction method to better solubilize membrane-associated proteins

    • Test different extraction buffers with varying detergent compositions

    • Increase antibody concentration or incubation time

    • Use enhanced sensitivity detection systems

    • Reduce washing stringency while maintaining specificity

    • Consider using concentration steps (e.g., immunoprecipitation) before detection

• Multiple bands or unexpected molecular weight:

  • Problem: Detection of additional bands beyond expected FMOGS-OX2 size

  • Methodological solutions:

    • Verify predicted molecular weight accounting for potential post-translational modifications

    • Include appropriate controls (knockout/knockdown samples)

    • Perform peptide competition assays to identify specific vs. non-specific bands

    • Use gradient gels for better resolution

    • Optimize sample preparation to reduce protein degradation (add protease inhibitors)

• Inconsistent results between experiments:

  • Problem: Variable detection between replicates or experiments

  • Methodological solutions:

    • Standardize all aspects of sample collection and processing

    • Prepare larger batches of working solutions to use across experiments

    • Include internal controls in each experiment for normalization

    • Maintain consistent incubation times and temperatures

    • Document and control for plant growth conditions that might affect expression

These troubleshooting approaches can significantly improve the reliability and specificity of FMOGS-OX2 detection in plant samples.

How can researchers differentiate between FMOGS-OX2 and closely related family members?

Differentiating between FMOGS-OX2 and structurally similar family members requires careful methodological considerations:

• Antibody selection and validation:

  • Epitope analysis:

    • Choose antibodies raised against unique regions of FMOGS-OX2 with minimal sequence homology to related proteins

    • If possible, use antibodies targeting N- or C-terminal regions that typically have greater sequence divergence

  • Cross-reactivity testing:

    • Test antibody against recombinant proteins of related family members if available

    • Include samples from plants overexpressing specific family members as controls

    • Perform Western blot analysis on tissues with known expression patterns of different family members

• Molecular techniques for validation:

  • Genetic approach:

    • Use FMOGS-OX2 knockout/knockdown plants to confirm antibody specificity

    • Compare with knockouts of related family members

    • Conduct complementation studies with tagged versions of FMOGS-OX2

  • Immunoprecipitation-Mass Spectrometry:

    • Perform immunoprecipitation with the FMOGS-OX2 antibody

    • Analyze precipitated proteins by mass spectrometry

    • Identify peptides unique to FMOGS-OX2 versus related proteins

• Experimental design considerations:

  • Tissue-specific analysis:

    • Focus on tissues with differential expression of FMOGS-OX2 versus related proteins

    • Use parallel RNA-seq or qRT-PCR to correlate transcript levels with protein detection

  • Multi-antibody approach:

    • When possible, use multiple antibodies targeting different epitopes of FMOGS-OX2

    • Compare detection patterns to identify consistent versus inconsistent signals

This comprehensive validation approach ensures that experimental results reflect FMOGS-OX2-specific detection rather than cross-reactivity with related family members.

What methodological adaptations are needed when analyzing FMOGS-OX2 in different plant tissues?

Analyzing FMOGS-OX2 across different plant tissues requires tissue-specific methodological adaptations:

• Tissue-specific extraction protocol modifications:

  • Leaf tissue:

    • Standard extraction buffers typically work well

    • Include higher concentrations of PVPP (2-3%) to remove phenolics and chlorophyll

  • Root tissue:

    • Increase detergent concentration to solubilize membrane-associated proteins

    • Add additional protease inhibitors to counter higher protease activity

  • Seed tissue:

    • Use specialized extraction buffers containing higher salt concentrations (300-500 mM NaCl)

    • Include lipid-removing components for oil-rich seeds

    • Consider pre-extraction steps to remove interfering compounds

• Sample loading and detection adjustments:

  • Protein concentration:

    • Adjust loading amounts based on typical FMOGS-OX2 expression in each tissue

    • For tissues with low expression, increase loading (50-100 μg) or use concentration methods

  • Exposure time optimization:

    • Use variable exposure times optimized for each tissue type

    • Consider digital imaging systems that allow multiple exposure captures

  • Background reduction:

    • Optimize blocking conditions specific to each tissue type

    • Test different blocking agents to counter tissue-specific non-specific binding

• Normalization strategy considerations:

  • Reference protein selection:

    • Choose tissue-appropriate reference proteins that maintain stable expression

    • Validate reference stability across tissues of interest

    • Consider using total protein normalization methods

  • Relative quantification:

    • Express results relative to a reference tissue with reliable FMOGS-OX2 expression

    • Use fold-change rather than absolute values when comparing across tissues

• Validation with complementary techniques:

  • Confirm expression patterns with qRT-PCR

  • Use immunohistochemistry to visualize tissue-specific localization

  • Correlate protein detection with tissue-specific metabolomic profiles

These adaptations ensure accurate detection and quantification of FMOGS-OX2 across diverse plant tissues with different biochemical compositions.

How does FMOGS-OX2 expression correlate with transcription factors like MYB28 in the glucosinolate pathway?

Understanding the relationship between FMOGS-OX2 and transcription factors like MYB28 requires integrated methodological approaches:

• Co-expression analysis framework:

  • Transcriptomic correlation:

    • Analyze RNA-seq data to calculate Pearson correlation coefficients between FMOGS-OX2 and MYB28 expression

    • Identify co-expression patterns across different tissues or conditions

  • Protein-level validation:

    • Use Western blot or ELISA to quantify both FMOGS-OX2 and MYB28 proteins

    • Determine if transcript correlations are maintained at protein level

• Regulatory relationship investigation:

  • Chromatin immunoprecipitation (ChIP) analysis:

    • Use anti-MYB28 antibodies to perform ChIP

    • Analyze enrichment of FMOGS-OX2 promoter regions by qPCR or sequencing

  • Transcription factor manipulation:

    • Analyze FMOGS-OX2 expression in MYB28 overexpression or knockout lines

    • Use inducible expression systems to track temporal dynamics of regulation

• Integration with existing knowledge:

  • In the glucosinolate pathway, research suggests MYB28 exhibits significant expression correlation with RsSUR1, potentially regulating multiple genes including FMOGS-OX2

  • Previous studies indicate MYB28 as an R2R3 transcription factor directly regulating aliphatic glucosinolate biosynthesis

  • The expression level of MYB28 has been positively correlated with glucoraphasatin (GRH) content in radish

• Network analysis approach:

  • Develop a co-expression network similar to that described in the literature:

    • Calculate correlation coefficients between gene expression levels

    • Establish significance thresholds (p ≤ 0.01)

    • Visualize interactions using network analysis tools

    • Identify direct and indirect regulatory relationships

This multi-faceted approach provides insights into the regulatory relationship between MYB28 and FMOGS-OX2, contributing to our understanding of transcriptional control in the glucosinolate biosynthetic pathway.

What methodological approaches can reveal FMOGS-OX2's role in plant response to environmental stresses?

To investigate FMOGS-OX2's involvement in plant stress responses, researchers should implement the following methodological approaches:

• Stress treatment experimental design:

  • Stress application protocol:

    • Apply defined stress conditions (drought, salinity, temperature, pathogens, herbivory)

    • Include appropriate controls for each stress treatment

    • Use time-course sampling to capture dynamic responses

  • Tissue sampling strategy:

    • Collect both stressed and control tissues at multiple time points

    • Sample specific tissues known to exhibit glucosinolate responses

    • Process samples consistently for both molecular and metabolite analyses

• Multi-level expression analysis:

  • Transcriptional regulation:

    • Perform qRT-PCR targeting FMOGS-OX2 and related pathway genes

    • Use RNA-seq for genome-wide context of stress response

  • Protein expression dynamics:

    • Quantify FMOGS-OX2 protein levels via Western blot or ELISA

    • Compare protein accumulation patterns with transcript dynamics

    • Assess post-translational modifications under stress conditions

• Functional characterization:

  • Genetic approach:

    • Compare stress responses in wild-type versus FMOGS-OX2 mutant/transgenic plants

    • Analyze overexpression lines to assess gain-of-function phenotypes

    • Perform complementation studies to confirm functional relationships

  • Metabolite profiling:

    • Measure changes in glucosinolate profiles using HPLC analysis

    • Quantify specific compounds like glucoraphasatin that are linked to FMOGS-OX2 activity

    • Correlate metabolite changes with FMOGS-OX2 expression patterns

• Integration with stress signaling pathways:

  • Hormone treatment studies:

    • Test effects of stress hormones (jasmonic acid, salicylic acid, abscisic acid) on FMOGS-OX2 expression

    • Use hormone biosynthesis/signaling mutants to establish pathway connections

  • Signaling inhibitor approach:

    • Apply specific inhibitors of stress signaling pathways

    • Determine effects on stress-induced FMOGS-OX2 expression

This comprehensive approach allows researchers to establish FMOGS-OX2's role in stress-responsive glucosinolate metabolism and its contribution to plant adaptive responses.

What are the key methodological considerations for researchers new to working with FMOGS-OX2 antibodies?

For researchers beginning work with FMOGS-OX2 antibodies, several key methodological considerations should be prioritized:

• Antibody selection and validation:

  • Choose antibodies with demonstrated specificity for FMOGS-OX2 rather than related family members

  • Verify reactivity with your plant species of interest (noted reactivity to Arabidopsis )

  • Validate specificity using appropriate controls (knockout/knockdown plants if available)

  • Test different antibody applications (Western blot and ELISA being most common )

• Sample preparation optimization:

  • Develop an efficient protein extraction protocol optimized for your specific plant tissue

  • Include adequate measures to counter plant-specific interfering compounds (phenolics, secondary metabolites)

  • Standardize sample collection, processing, and storage procedures

  • Determine appropriate protein amounts and dilutions for consistent detection

• Experimental design considerations:

  • Include appropriate positive and negative controls in all experiments

  • Design experiments with sufficient biological and technical replication

  • Establish consistent normalization strategies for quantitative comparisons

  • Plan for integrated analyses that connect protein expression with transcript levels and glucosinolate metabolites

• Data interpretation framework:

  • Consider FMOGS-OX2's role in the broader glucosinolate pathway context

  • Interpret results in light of tissue-specific expression patterns

  • Account for post-translational modifications that may affect detection

  • Correlate protein data with metabolic outcomes (glucosinolate profiles)

By addressing these methodological considerations systematically, new researchers can establish robust protocols for FMOGS-OX2 antibody applications, enabling reliable investigation of this important enzyme in plant glucosinolate metabolism.

How might future antibody development enhance FMOGS-OX2 research capabilities?

The future of FMOGS-OX2 research could be significantly advanced through targeted antibody development strategies:

• Epitope-specific antibody design:

  • Generate antibodies against distinct functional domains of FMOGS-OX2

  • Develop antibodies that recognize specific post-translational modifications

  • Create antibodies that differentiate between FMOGS-OX2 and closely related family members

  • Design species-specific antibodies for comparative studies across plant families

• Advanced antibody formats:

  • Single-chain variable fragments (scFvs) for improved tissue penetration in immunohistochemistry

  • Recombinant antibodies with standardized production for better consistency

  • Nanobodies (single-domain antibodies) for applications requiring small probe size

  • Bi-specific antibodies for simultaneous detection of FMOGS-OX2 and interacting proteins

• Application-optimized modifications:

  • Directly conjugated fluorophores for multiplexed immunofluorescence

  • Enzyme-conjugated formats for sensitivity enhancement

  • Mass cytometry-compatible metal-conjugated antibodies for high-dimensional analyses

  • Proximity ligation-compatible antibody pairs for in situ interaction studies

• Validation and standardization:

  • Comprehensive cross-reactivity profiling against all related family members

  • Standardized validation datasets across multiple plant species and tissues

  • Benchmark antibodies against genetic tools (CRISPR knockouts, tagged lines)

  • Open-source sharing of validation protocols and results